Reagents and supplies for PacBio Revio HiFi sequencing platform

The U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) is procuring reagents and supplies for their existing PacBio Revio HiFi sequencing platform to support error-corrected next generation sequencing for a tobacco-derived nicotine (TDN) mutations study. The requirement encompasses five line items configured as "Brand Name or Equal" specifications: 12 each of Revio SMRT Cell trays and SPRQ sequencing plates, 1 each of Sequencer pipet tips and SMRT Bell Adapter index plate 96A, and 2 each of SMRT Bell Prep kits 3.0. All items must be compatible with the existing PacBio Revio system (Serial Number 84183) and include a 6-month warranty from FDA acceptance. The solicitation is structured as a Request for Quote (RFQ) under number 75F40125Q130433, with quotes due exclusively by email to Warren Dutter at warren.dutter@fda.hhs.gov by August 12, 2025, at 1:00 P.M. Central Time. The contract will be awarded as firm fixed price with Net 30 day payment terms after government acceptance, and offerors must provide Accessibility Conformance Reports for Section 508 compliance.

This procurement is designated as a total small business set-aside under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees, and no incumbent contractors are identified in the solicitation documents. While no specific contract value is disclosed, the requirement involves purchasing laboratory consumables and reagents for a specialized sequencing platform used in toxicological research. The successful contractor must deliver all items within 90 calendar days of award under FOB destination terms to the FDA-NCTR facility located in Jefferson, Arkansas 72079. All quotes must be submitted inclusive of delivery costs, and the items will support ongoing research operations at the federal laboratory facility.